Stocks Health care LFMD
NASDAQ · Health careLifeMD, Inc. (LFMD)
LifeMD, Inc. brought in $191.6M of revenue over the twelve months to June 30, 2026, up 19.8% from a year earlier. Net income was $201K, a net margin of 0.1%. Operating cash flow minus capital spending left $6.4M of free cash flow in fiscal 2025. At June 30, 2026 it held $25.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
Watch LFMD in 60 secondsWhat LifeMD, Inc. does
LifeMD, Inc. is registered with the SEC under industry code SIC 8011 (Services-Offices & Clinics of Doctors of Medicine). Its shares trade on NASDAQ under the ticker LFMD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $194.1M | $14.4M | $0.25 | $6.4M |
| 2024 | $154.8M | -$21.4M | -$0.60 | $16M |
| 2023 | $152.5M | -$20.6M | n/a | $8.6M |
| 2022 | $119M | -$45.5M | n/a | -$23.3M |
| 2021 | $92.9M | -$60.9M | n/a | -$33.3M |
| 2020 | $37.3M | -$58.6M | n/a | n/a |
Full financial statements: income, balance sheet and cash flow
Where LFMD ranks in Health care
Dividends
It paid out $3.1M in cash dividends, 22% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | n/a | $3.1M | 22% |
| 2024 | n/a | $3.1M | n/a |
| 2023 | n/a | $3.1M | n/a |
| 2022 | n/a | $3.1M | n/a |
| 2021 | n/a | $871.5K | n/a |
| 2015 | n/a | $10.8K | n/a |
Latest SEC filings
What LifeMD, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 25, 2026
- September 15, 2026
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 3.5% to $47.3M versus the same quarter last year; diluted EPS -$0.16 versus -$0.05.
- August 5, 2026
- June 22, 2026
- May 6, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 1.4% to $50.2M versus the same quarter last year; diluted EPS -$0.20 versus -$0.02.
- May 6, 2026
- April 30, 2026
- April 30, 2026Additional proxy material DEFA14A
- April 30, 2026Additional proxy material DEFA14A
What is LFMD worth? A DCF from its reported cash flow
Insider trades
What the people running LifeMD, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 5 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 11, 2026 | Strawn John R JrDirector | Received as pay | 35,000 | - |
| August 11, 2026 | Larovere JoanDirector | Received as pay | 35,000 | - |
| August 11, 2026 | Macrae Calum ArchibaldDirector | Received as pay | 35,000 | - |
| August 11, 2026 | Simon RobertoDirector | Received as pay | 35,000 | - |
| August 11, 2026 | DiTrolio JosephDirector | Received as pay | 35,000 | - |
| June 1, 2026 | Sripad UmeshChief Technology Officer | Received as pay | 75,000 | - |
| May 11, 2026 | Kavthekar AtulChief Financial Officer | Received as pay | 337,500 | - |
| May 4, 2026 | Strawn John R JrDirector | Received as pay | 50,000 | - |
| May 4, 2026 | Simon RobertoDirector | Received as pay | 50,000 | - |
| March 30, 2026 | Pisano Christopher AChief Marketing Officer | Received as pay | 200,000 | - |
| December 9, 2025 | Friedeman JessicaChief Marketing Officer | Sold | 15,000 | $54.2K |
| October 6, 2025 | Larovere JoanDirector | Received as pay | 22,365 | - |
| October 6, 2025 | Strawn John R JrDirector | Received as pay | 22,365 | - |
| October 2, 2025 | Simon RobertoDirector | Received as pay | 22,365 | - |
| October 2, 2025 | Macrae Calum ArchibaldDirector | Received as pay | 22,365 | - |
Who owns LFMD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
9 insiders reported holding 2,128,004 shares in total, about $6.2M at the last price.
| Holder | Shares |
|---|---|
| Strawn John R JrDirector | 498,001 |
| Kavthekar AtulChief Financial Officer | 337,500 |
| DiTrolio JosephDirector | 308,413 |
| Simon RobertoDirector | 288,175 |
| Friedeman JessicaChief Marketing Officer | 205,000 |
| Pisano Christopher AChief Marketing Officer | 200,000 |
| Larovere JoanDirector | 142,050 |
| Sripad UmeshChief Technology Officer | 75,000 |
| Macrae Calum ArchibaldDirector | 73,865 |
Questions about LFMD
What does LifeMD, Inc. do?
LifeMD, Inc. is registered with the SEC under industry code SIC 8011 (Services-Offices & Clinics of Doctors of Medicine). Its shares trade on NASDAQ under the ticker LFMD.
Is LifeMD, Inc. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $201K on revenue of $191.6M, a net margin of 0.1%.
How much revenue does LifeMD, Inc. make?
Over the twelve months to June 30, 2026 LifeMD, Inc. reported revenue of $191.6M. That is 19.8% more than a year earlier.
When did LifeMD, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the employee stock plan registration from September 25, 2026.
Similar companies
Compare LFMD with
Follow LFMD
Get an email when LifeMD, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow LFMD: get an email when it filesWhere the numbers come from
Financial figures are the values LifeMD, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.